BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36867206)

  • 1. Never in mitosis gene A-related kinase-6 deficiency deteriorates diabetic cardiomyopathy via regulating heat shock protein 72.
    Shao S; Xiao L; Jia M; Zhang C; Zhao G; Yao R; Wang X; Gao L
    J Mol Med (Berl); 2023 Apr; 101(4):419-430. PubMed ID: 36867206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Heme Oxygenase 1 in the Protective Effect of Caloric Restriction against Diabetic Cardiomyopathy.
    Waldman M; Nudelman V; Shainberg A; Zemel R; Kornwoski R; Aravot D; Peterson SJ; Arad M; Hochhauser E
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31100876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KLF9 Aggravates Streptozotocin-Induced Diabetic Cardiomyopathy by Inhibiting PPARγ/NRF2 Signalling.
    Li F; Peng J; Feng H; Yang Y; Gao J; Liu C; Xu J; Zhao Y; Pan S; Wang Y; Xu L; Qian W; Zong J
    Cells; 2022 Oct; 11(21):. PubMed ID: 36359788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Never in mitosis gene A related kinase-6 attenuates pressure overload-induced activation of the protein kinase B pathway and cardiac hypertrophy.
    Bian Z; Liao H; Zhang Y; Wu Q; Zhou H; Yang Z; Fu J; Wang T; Yan L; Shen D; Li H; Tang Q
    PLoS One; 2014; 9(4):e96095. PubMed ID: 24763737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Luteolin protects against diabetic cardiomyopathy by inhibiting NF-κB-mediated inflammation and activating the Nrf2-mediated antioxidant responses.
    Li L; Luo W; Qian Y; Zhu W; Qian J; Li J; Jin Y; Xu X; Liang G
    Phytomedicine; 2019 Jun; 59():152774. PubMed ID: 31009852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nrf2 prevents diabetic cardiomyopathy via antioxidant effect and normalization of glucose and lipid metabolism in the heart.
    Yang G; Zhang Q; Dong C; Hou G; Li J; Jiang X; Xin Y
    J Cell Physiol; 2024 Feb; 239(2):e31149. PubMed ID: 38308838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LAZ3 protects cardiac remodeling in diabetic cardiomyopathy via regulating miR-21/PPARa signaling.
    Gao L; Liu Y; Guo S; Xiao L; Wu L; Wang Z; Liang C; Yao R; Zhang Y
    Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3322-3338. PubMed ID: 30031228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Aza resveratrol-chalcone derivative 6b protects mice against diabetic cardiomyopathy by alleviating inflammation and oxidative stress.
    You S; Qian J; Sun C; Zhang H; Ye S; Chen T; Xu Z; Wang J; Huang W; Liang G
    J Cell Mol Med; 2018 Mar; 22(3):1931-1943. PubMed ID: 29327811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Akap1 deficiency exacerbates diabetic cardiomyopathy in mice by NDUFS1-mediated mitochondrial dysfunction and apoptosis.
    Qi B; He L; Zhao Y; Zhang L; He Y; Li J; Li C; Zhang B; Huang Q; Xing J; Li F; Li Y; Ji L
    Diabetologia; 2020 May; 63(5):1072-1087. PubMed ID: 32072193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-20a-5p overexpression prevented diabetic cardiomyopathy via inhibition of cardiomyocyte apoptosis, hypertrophy, fibrosis and JNK/NF-κB signalling pathway.
    Liu X; Guo B; Zhang W; Ma B; Li Y
    J Biochem; 2021 Oct; 170(3):349-362. PubMed ID: 33837411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sinapic acid ameliorates cardiac dysfunction and cardiomyopathy by modulating NF-κB and Nrf2/HO-1 signaling pathways in streptozocin induced diabetic rats.
    Raish M; Ahmad A; Bin Jardan YA; Shahid M; Alkharfy KM; Ahad A; Ansari MA; Abdelrahman IA; Al-Jenoobi FI
    Biomed Pharmacother; 2022 Jan; 145():112412. PubMed ID: 34768051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoliquiritigenin attenuates diabetic cardiomyopathy via inhibition of hyperglycemia-induced inflammatory response and oxidative stress.
    Gu X; Shi Y; Chen X; Sun Z; Luo W; Hu X; Jin G; You S; Qian Y; Wu W; Liang G; Wu G; Chen Z; Chen X
    Phytomedicine; 2020 Nov; 78():153319. PubMed ID: 32950951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of diabetic cardiomyopathy by caloric restriction is mediated by intracellular signaling pathways involving 'SIRT1 and PGC-1α'.
    Waldman M; Cohen K; Yadin D; Nudelman V; Gorfil D; Laniado-Schwartzman M; Kornwoski R; Aravot D; Abraham NG; Arad M; Hochhauser E
    Cardiovasc Diabetol; 2018 Aug; 17(1):111. PubMed ID: 30071860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6-Gingerol Alleviates Ferroptosis and Inflammation of Diabetic Cardiomyopathy via the Nrf2/HO-1 Pathway.
    Wu S; Zhu J; Wu G; Hu Z; Ying P; Bao Z; Ding Z; Tan X
    Oxid Med Cell Longev; 2022; 2022():3027514. PubMed ID: 36624878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cathelicidin-WA ameliorates diabetic cardiomyopathy by inhibiting the NLRP3 inflammasome.
    Peng M; Liu Y; Xu Y; Li L; Li Y; Yang H
    Cell Cycle; 2021 Nov; 20(21):2278-2290. PubMed ID: 34585633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RTA 408 ameliorates diabetic cardiomyopathy by activating Nrf2 to regulate mitochondrial fission and fusion and inhibiting NF-κB-mediated inflammation.
    Hao J; Zhou J; Hu S; Zhang P; Wu H; Yang J; Zhao B; Liu H; Lin H; Chi J; Lou D
    Am J Physiol Cell Physiol; 2024 Feb; 326(2):C331-C347. PubMed ID: 38047307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol alleviates diabetic cardiomyopathy in rats by improving mitochondrial function through PGC-1α deacetylation.
    Fang WJ; Wang CJ; He Y; Zhou YL; Peng XD; Liu SK
    Acta Pharmacol Sin; 2018 Jan; 39(1):59-73. PubMed ID: 28770830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syringaresinol Protects against Type 1 Diabetic Cardiomyopathy by Alleviating Inflammation Responses, Cardiac Fibrosis, and Oxidative Stress.
    Li G; Yang L; Feng L; Yang J; Li Y; An J; Li D; Xu Y; Gao Y; Li J; Liu J; Yang L; Qi Z
    Mol Nutr Food Res; 2020 Sep; 64(18):e2000231. PubMed ID: 32729956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GCN2 deficiency ameliorates cardiac dysfunction in diabetic mice by reducing lipotoxicity and oxidative stress.
    Feng W; Lei T; Wang Y; Feng R; Yuan J; Shen X; Wu Y; Gao J; Ding W; Lu Z
    Free Radic Biol Med; 2019 Jan; 130():128-139. PubMed ID: 30389499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential of chrysophanol in protecting against high fat-induced cardiac injury through Nrf2-regulated anti-inflammation, anti-oxidant and anti-fibrosis in Nrf2 knockout mice.
    Lian Y; Xia X; Zhao H; Zhu Y
    Biomed Pharmacother; 2017 Sep; 93():1175-1189. PubMed ID: 28738526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.